Research is an integral part of the Don & Erika Wallace Comprehensive Breast Program at Moffitt Cancer Center. Our dedication to facilitating advances in breast cancer care is evidenced by our ambitious clinical trial program, which allows patients to receive many of the latest advancements in treatment before they are made widely available. This focus on research is one of the primary reasons why many physicians choose to refer their patients to Moffitt for cancer treatment.
What sets us apart
Moffitt’s breast cancer program is leading the charge in discovering breast cancer breakthroughs. Overseen by Breast Program Research Director Dr. Heather Han, our team spearheads multiple clinical trials every year with the goal of improving how breast malignances are diagnosed, evaluated and treated. We also focus on the patient as a whole—not just the clinical aspect of disease—and seek ways to reduce side effects of treatment and enhance quality of life.
Many of our breast cancer clinical trials concentrate on:
- Targeted therapies
- Novel chemotherapy combinations
Furthermore, Moffitt is among a select few specialty clinics in the country to be designated as a Comprehensive Cancer Center by the National Cancer Institute. This speaks directly to our unwavering commitment to research and progressive approach to treatment. Currently, Moffitt is the only Florida-based cancer center to hold this distinction.
Learn more about Moffitt’s clinical trials for breast cancer
If you are a referring physician who would like learn what clinical trials are currently available to breast cancer patients, call 1-813-745-6100 or 1-800-679-0775 (toll-free), or submit a clinical trial inquiry form. To refer a patient to Moffitt’s breast cancer program, complete our online form or contact a physician liaison for assistance. Our team emphasizes timely responses and clear communication with referring physicians to ensure a seamless care experience for patients. A 24/7 hotline is also available to referring physicians for questions and record requests.